{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:04:15Z","timestamp":1777896255405,"version":"3.51.4"},"reference-count":73,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Linacre Q"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>Medication abortion represents more than 50 percent of abortions in the United States (US). Since its approval in the US in 2000, the Food and Drug Administration (FDA) has progressively relaxed the prescribing requirements such that currently, no office visit, in-person dispensing, or ultrasound is required. Obtaining medication for abortion online without medical supervision or evaluation is also possible. This article reviews the complications of medication abortion by examining major studies and delineates the risks specific to self-managed abortion to inform clinicians in caring for women.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Medication abortion has become the most common abortion method in the United States. This document provides a detailed history of the relaxation requirements on medication abortion and reviews the major studies on medication abortion complications including a discussion of their limitations. Finally, the paper delineates the ease of access to medication abortion without a health care provider and the risks associated with self-managed abortion. This paper is intended to provide information for clinicians who likely will be encountering increasing number of patients with such complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00243639221128389","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T04:59:57Z","timestamp":1670821197000},"page":"273-289","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-Managed Medication Abortion: Implications for Clinical Practice"],"prefix":"10.1177","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-6529","authenticated-orcid":false,"given":"Christina A.","family":"Cirucci","sequence":"first","affiliation":[{"name":"Charlotte Lozier Institute, Arlington, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"bibr1-00243639221128389","unstructured":"Abortion Care Network. 2020. \u201cCommunities Need Clinics: The Essential Role of Independent Abortion Clinics in the United States.\u201d https:\/\/abortioncarenetwork.org\/wp-content\/uploads\/2020\/12\/CommunitiesNeedClinics-2020.pdf."},{"issue":"5","key":"bibr2-00243639221128389","first-page":"e150","volume":"129","author":"ACOG","journal-title":"Obstetrics & Gynecology"},{"issue":"2","key":"bibr3-00243639221128389","first-page":"e57","volume":"130","author":"ACOG","journal-title":"Obstetrics & Gynecology"},{"key":"bibr4-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002560"},{"key":"bibr5-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004082"},{"key":"bibr6-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004247"},{"key":"bibr7-00243639221128389","unstructured":"\u201cAid Access.\u201d (website). Accessed June 8, 2022. https:\/\/aidaccess.org\/en\/i-need-an-abortion. https:\/\/aidaccess.org\/en\/page\/561\/who-are-we."},{"key":"bibr8-00243639221128389","first-page":"1","author":"Aiken A. R. A.","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"bibr9-00243639221128389","unstructured":"American College of Obstetricians and Gynecologists et al., v. Food and Drug Administration et al., No. 20-1320, 2020 WL. 3960625 (D. Md. July 13, 2020). 2020. Accessed June 16, 2022. https:\/\/www.docketalarm.com\/cases\/Maryland_District_Court\/8\u201320-cv01320\/American_College_of_Obstetricians_%26_Gynecologists_et_al_v._United_States_Food_and_Drug_Administration_et_al\/132\/."},{"key":"bibr10-00243639221128389","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.12.8222"},{"issue":"1","key":"bibr11-00243639221128389","first-page":"3","volume":"36","author":"Aultman K.","year":"2021","journal-title":"Issues Law Med"},{"key":"bibr12-00243639221128389","first-page":"1","volume-title":"StatPearls","author":"Autry B. M.","year":"2022"},{"key":"bibr13-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000116260.81570.60"},{"key":"bibr14-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2003.09.065"},{"key":"bibr15-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-018-0645-6"},{"key":"bibr16-00243639221128389","unstructured":"Center for Drug Evaluation and Research. 2000. \u201cApproval Letter for Mifeprex NDA 20-687, September 28, 2000.\u201d https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2000\/20687appltr.pdf."},{"key":"bibr17-00243639221128389","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"bibr18-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000897"},{"key":"bibr19-00243639221128389","first-page":"8","author":"Cirucci C. A.","year":"2021","journal-title":"Health Serv Res Manag Epidemiol"},{"key":"bibr20-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182755763"},{"key":"bibr21-00243639221128389","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"bibr22-00243639221128389","unstructured":"Department of Health and Human Services, Centers for Disease Control and Prevention, Food and Drug Administration, and National Institutes of Health. 2006. \u201cEmerging Clostridial Disease Workshop May 11, 2006, Atlanta, Georgia, Certified Verbatim Transcript.\u201d Emerging Clostridial Disease Workshop, Atlanta, GA, May 11, 2006. Accessed June 16, 2022. https:\/\/aaplog.wildapricot.org\/resources\/2006%20CDC%20FDA%20Clostridial%20Disease%20Transcript.pdf."},{"key":"bibr23-00243639221128389","unstructured":"\u201cDoctor sentenced for spiking girlfriend's drink to induce abortion.\u201d 2018. Accessed June 9, 2022. https:\/\/www.cbsnews.com\/news\/sikander-imran-doctor-sentenced-for-spiking-girlfriends-drink-to-induce-abortion\/."},{"key":"bibr24-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmwh.2009.12.017"},{"key":"bibr25-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15684"},{"key":"#cr-split#-bibr26-00243639221128389.1","unstructured":"FDA. 2011. \"NDA 20-687 MIFEPREX (mifepristone) Tablets, 200 mg"},{"key":"#cr-split#-bibr26-00243639221128389.2","unstructured":"Risk Evaluation and Mitigation Strategy (REMS).\" Accessed June 16, 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/rems\/Mifeprex_2011-06-08_Full.pdf."},{"key":"bibr27-00243639221128389","unstructured":"FDA. 2018. \u201cRCM # 2007-525, NDA 20-687, Mifepristone US Post-Marketing Adverse Events Summary through 12\/31\/2018.\u201d Accessed June 16, 2022. https:\/\/www.fda.gov\/media\/112118\/download."},{"key":"bibr28-00243639221128389","unstructured":"FDA. 2019. \u201cWarning Letter Aidaccess.org MARCS-CMS 575658 - March 08, 2019. edited by FDA.\u201d Accessed June 16, 2022. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/aidaccessorg-575658-03082019."},{"key":"bibr29-00243639221128389","unstructured":"FDA. 2021a. \u201cQuestions and Answers on Mifeprex.\u201d Accessed June 16, 2022. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/questions-and-answers-mifeprex; https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/questions-and-answers-mifeprex."},{"key":"bibr30-00243639221128389","unstructured":"FDA. 2021b. \u201cRisk Evaluation and Mitigation Strategies, REMS.\u201d Last Modified December 17, 2021. Accessed June 12. 2022. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/risk-evaluation-and-mitigation-strategies-rems."},{"key":"bibr31-00243639221128389","unstructured":"\u201cFDA Adverse Event Reporting System.\u201d (website). Accessed June 8, 2022. https:\/\/fis.fda.gov\/sense\/app\/95239e26-e0be-42d9-a960-9a5f7f1c25ee\/sheet\/7a47a261-d58b-4203-a8aa-6d3021737452\/state\/analysis."},{"key":"bibr32-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01956-5"},{"key":"bibr33-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G481"},{"key":"bibr34-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2015.01.005"},{"key":"bibr35-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004756"},{"key":"bibr36-00243639221128389","doi-asserted-by":"publisher","DOI":"10.5694\/mja12.10297"},{"key":"bibr37-00243639221128389","unstructured":"Gomperts. 2019. \u201cFDA vs. Aid Access: Aid Access Will Continue Providing Abortion Care.\u201d Last Modified April 2019. Accessed June 12, 2022. https:\/\/aidaccess.org\/en\/page\/200797\/fda-vs-aid-access."},{"key":"bibr38-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002212"},{"key":"bibr39-00243639221128389","unstructured":"Guttmacher Institute. 2022a. \u201cMedication Abortion Now Accounts for More Than Half of All US Abortions.\u201d Policy Analysis. Accessed June 16, 2022. https:\/\/www.guttmacher.org\/article\/2022\/02\/medication-abortion-now-accounts-more-half-all-us-abortions."},{"key":"bibr40-00243639221128389","unstructured":"Guttmacher Institute. 2022b. \u201cMedication Abortion: State Laws and Policies as of June 1, 2022.\u201d State Laws and Policies. Accessed June 17, 2022. https:\/\/www.guttmacher.org\/state-policy\/explore\/medication-abortion."},{"key":"bibr41-00243639221128389","unstructured":"Gynuity. \u201cTelAbortion: Safe. Effective. Private. Convenient.\u201d (website). Accessed June 8, 2022. https:\/\/telabortion.org\/."},{"key":"bibr42-00243639221128389","unstructured":"Hearn Law PLC, Richard A. Hearn. 2019. \u201cRE: Warning Letter to Aidaccess.org and Dr. Rebecca Gomperts dated March 8, 2019.\u201d Accessed June 1, 2022. https:\/\/aidaccess.org\/en\/media\/inline\/2019\/5\/16\/19_05_16_gomperts_letter_and_exhibit_a.pdf."},{"key":"bibr43-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000910"},{"key":"bibr44-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2012.10.024"},{"key":"bibr45-00243639221128389","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss7009a1"},{"issue":"1","key":"bibr46-00243639221128389","first-page":"61","volume":"23","author":"Lederer L.","year":"2014","journal-title":"Annals of Health Law"},{"key":"bibr47-00243639221128389","unstructured":"\"Man accused of killing fetus with \u201cabortion pancake.\u201d 2014.\n                      CBS News\n                      . Last Modified July 14, 2014. Accessed June 16, 2022. https:\/\/www.cbsnews.com\/news\/man-accused-of-killing-fetus-with-abortion-pancake\/."},{"key":"bibr48-00243639221128389","unstructured":"McBride Jeannie. 2017. \u201cDoctor accused of spiking a local woman's drink with an abortion pill.\u201d Accessed June 16, 2022. https:\/\/www.rochesterfirst.com\/news\/local-news\/doctor-accused-of-spiking-a-local-womans-drink-with-an-abortion-pill\/880161122\/."},{"key":"bibr49-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der016"},{"key":"bibr50-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G189"},{"key":"bibr51-00243639221128389","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"bibr52-00243639221128389","first-page":"1","volume-title":"The Safety and Quality of Abortion Care in the United States","author":"National Academies of Science, Engineering, &amp; Medicine","year":"2018"},{"key":"bibr53-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181b5ccf9"},{"issue":"1","key":"bibr54-00243639221128389","volume":"9","author":"Nivedita K.","year":"2015","journal-title":"Journal of Clinical and Diagnostic Research"},{"key":"bibr55-00243639221128389","unstructured":"Pfizer. 2021. \u201cCytotec misoprostol tablets.\u201d https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?format=PDF&id=559."},{"key":"bibr56-00243639221128389","unstructured":"\u201cPlan C Guide to Abortion Pills, The: How to get abortion pill access by mail in Texas.\u201d Plan C (website), accessed August 10, 2022. https:\/\/www.plancpills.org\/states\/texas."},{"key":"bibr57-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2019.05.013"},{"key":"bibr58-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2012.06.011"},{"key":"bibr59-00243639221128389","unstructured":"\u201cSafe at-home abortion is here, A.\u201d Plan C (website). Accessed June 8, 2022. https:\/\/www.plancpills.org."},{"key":"bibr60-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13797"},{"key":"bibr61-00243639221128389","unstructured":"Siewert, Shereen. 2022. \u201cFormer Wausau-area man convicted of trying to kill unborn child with abortion pill.\u201d Last Modified April 29, 2022. Accessed June 9, 2022. https:\/\/wausaupilotandreview.com\/2022\/04\/29\/former-wausau-area-man-convicted-of-trying-to-kill-unborn-child-with-abortion-pill\/."},{"key":"bibr62-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1177\/23333928211053965"},{"key":"bibr63-00243639221128389","unstructured":"Supreme Court of the US. 2021. \u201cFood and Drug Administration, et al. v. American College of Obstetricians and Gynecologists, et al. On Application for Stay. In 20A34 20a34.\u201d https:\/\/www.supremecourt.gov\/opinions\/20pdf\/20a34_3f14.pdf."},{"key":"bibr64-00243639221128389","unstructured":"Supreme Court of the United States. 2022. Dobbs, States Health Office of the Mississippi Department of Health, et al., v. Jackson Women's Health Organization et al. In 19-1392, edited by Supreme Court of the United States. 19-1392 Dobbs v. Jackson Women's Health Organization (06\/24\/2022) (supremecourt.gov)."},{"key":"bibr65-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000603"},{"key":"bibr66-00243639221128389","unstructured":"US Census Bureau. 2021 \u201cQuick Facts.\u201d Accessed August 5, 2022. https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/RHI725221."},{"key":"bibr67-00243639221128389","unstructured":"US Government Accountability Office. 2018. \u201cGAO-18-292 Information on Mifeprex Labeling Changes and Ongoing Monitoring Efforts.\u201d Accessed June 16, 2022. https:\/\/www.gao.gov\/assets\/700\/690914.pdf."},{"key":"bibr68-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2012.11.009"},{"key":"bibr69-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.13354"},{"key":"bibr70-00243639221128389","unstructured":"\u201cWisconsin man spikes mistress\u2019s drink with abortion drug, gets 22 years in prison.\u201d 2018. Last Modified October 12, 2018. Accessed June 9, 2022. https:\/\/www.lifesitenews.com\/news\/wisconsin-husband-spikes-mistresss-drink-with-abortion-drug-gets-22-years\/."},{"key":"bibr71-00243639221128389","unstructured":"Woodcock Janet. 2021. \u201cFDA Letter to ACOG.\u201d 2. https:\/\/www.sba-list.org\/wp-content\/uploads\/2021\/04\/govdoc20210412-226601.pdf."},{"key":"bibr72-00243639221128389","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.181172"}],"container-title":["The Linacre Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00243639221128389","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00243639221128389","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00243639221128389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:20:05Z","timestamp":1777623605000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00243639221128389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1177\/00243639221128389"],"URL":"https:\/\/doi.org\/10.1177\/00243639221128389","relation":{},"ISSN":["0024-3639","2050-8549"],"issn-type":[{"value":"0024-3639","type":"print"},{"value":"2050-8549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]}}}